ES2053637T3 - Anticuerpos monoclonales de sustancia que enlaza antitrombina y sus usos. - Google Patents

Anticuerpos monoclonales de sustancia que enlaza antitrombina y sus usos.

Info

Publication number
ES2053637T3
ES2053637T3 ES88112047T ES88112047T ES2053637T3 ES 2053637 T3 ES2053637 T3 ES 2053637T3 ES 88112047 T ES88112047 T ES 88112047T ES 88112047 T ES88112047 T ES 88112047T ES 2053637 T3 ES2053637 T3 ES 2053637T3
Authority
ES
Spain
Prior art keywords
substance
antithrombine
links
monoclonal antibodies
monoclonal antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88112047T
Other languages
English (en)
Inventor
Nobuo Aoki
Takao Nagoya
Shigeru Kimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Application granted granted Critical
Publication of ES2053637T3 publication Critical patent/ES2053637T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

EL PRESENTE INVENTO PROVEE UN ANTICUERPO MONOCLONAL ESPECIFICO PARA UNA SUSTANCIA (TM) ASTRINGENTE DE TROMBOSIS, HIBRIDOMAS QUE PRODUCEN EL ANTICUERPO MONOCLONAL, UN PROCESO DE PURIFICACION DE TM QUE DESCRIBE EL USO DEL ANTICUERPO MONOCLONAL COMO UN INMUNO ADSORBENTE, COMO TAMBIEN UN INMUNO ENSAYO DE TM QUE DESCRIBE EL USO DEL ANTICUERPO MONOCLONAL.
ES88112047T 1987-08-13 1988-07-26 Anticuerpos monoclonales de sustancia que enlaza antitrombina y sus usos. Expired - Lifetime ES2053637T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP62202517A JPS6445398A (en) 1987-08-13 1987-08-13 Antithrombin-binding substance monoclonal antibody, hybridoma producing said antibody and method for purifying and measuring thrombin-binding substance utilizing said monoclonal antibody
JP4216068A JPH05304953A (ja) 1987-08-13 1992-08-13 抗トロンビン結合性物質モノクローナル抗体を産生するハイブリドーマ

Publications (1)

Publication Number Publication Date
ES2053637T3 true ES2053637T3 (es) 1994-08-01

Family

ID=26513431

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88112047T Expired - Lifetime ES2053637T3 (es) 1987-08-13 1988-07-26 Anticuerpos monoclonales de sustancia que enlaza antitrombina y sus usos.

Country Status (7)

Country Link
US (1) US5098829A (es)
EP (1) EP0306680B1 (es)
JP (2) JPS6445398A (es)
KR (1) KR960002740B1 (es)
CA (1) CA1335180C (es)
DE (1) DE3888604T2 (es)
ES (1) ES2053637T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006857A1 (en) * 1989-11-02 1991-05-16 Teijin Limited Immunoassay of human thrombomodulin, and reagent and kit therefor
JPH0736019B2 (ja) * 1989-12-27 1995-04-19 富士薬品工業株式会社 新規な抗ヒトトロンボモジュリンモノクローナル抗体によるヒトトロンボモジュリンおよびその分解産物の定量方法
JP2697289B2 (ja) * 1990-11-10 1998-01-14 ブラザー工業株式会社 ミシンのための駆動装置
US7240940B2 (en) * 2004-09-23 2007-07-10 89908, Inc. Vehicle cargo bed extender
WO2013073545A1 (ja) 2011-11-15 2013-05-23 旭化成ファーマ株式会社 敗血症の治療及び／又は改善のための医薬
CN104394885B (zh) 2012-05-31 2017-06-30 学校法人近畿大学 抗癌剂所致的末梢神经障碍性疼痛的预防和/或治疗剂
WO2020067389A1 (ja) 2018-09-28 2020-04-02 旭化成ファーマ株式会社 抗悪性腫瘍剤による末梢神経障害の症状軽減及び／又は発症抑制のための医薬
MX2021004511A (es) 2018-10-22 2021-06-08 Asahi Kasei Pharma Corp Medicamento para el tratamiento y/o mejora de la septicemia asociada con la anomalia de la coagulacion.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
ATE113062T1 (de) * 1986-07-15 1994-11-15 Kowa Co Throminbindende substanz und verfahren zu ihrer herstellung.
DE3876124T2 (de) * 1987-04-01 1993-05-06 Mitsubishi Gas Chemical Co Immunoassay fuer thrombomodulin.

Also Published As

Publication number Publication date
CA1335180C (en) 1995-04-11
EP0306680A2 (en) 1989-03-15
KR890003405A (ko) 1989-04-14
DE3888604D1 (de) 1994-04-28
JPH058679B2 (es) 1993-02-02
EP0306680A3 (en) 1990-02-28
JPS6445398A (en) 1989-02-17
JPH05304953A (ja) 1993-11-19
KR960002740B1 (ko) 1996-02-26
DE3888604T2 (de) 1994-10-27
US5098829A (en) 1992-03-24
EP0306680B1 (en) 1994-03-23

Similar Documents

Publication Publication Date Title
ES2109254T3 (es) Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
ES2075327T3 (es) Metodo para multiplicar linfocitos de sangre periferica humana in vitro que producen anticuerpos monoclonales especificos para un antigeno.
ES2304795T3 (es) Anticuerpos agonistas para el receptor de trombopoyetina y sus usos terapeuticos.
CO4480111A1 (es) Anticuerpos monoclonales de mono especificos para humanos b7. y/o b7.2, formas primatizadas de los mismos, composicio- nes farmaceuticas que los contienen, y uso de los mismos co- mo inmunosupresantes
ES2054644T3 (es) Anticuerpo contra interleucina-1.
ES2074062T3 (es) Inmunoensayo para antigenos hiv-1 que utilizan fragmentos de f(ab')2 como sonda.
FI960567A0 (fi) Monoklonaalinen vasta-aine, joka indusoi apoptoosin
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
DK279283A (da) Rem, f.eks. urrem
MX2024010955A (es) Nuevos anticuerpos anti-cd3 y usos de los mismos
MX9302461A (es) Benzo-y piridopiridonas sustituidas por sulfonilbencilo, procedimiento para su obtencion y medicamentos que las contienen.
ES2053637T3 (es) Anticuerpos monoclonales de sustancia que enlaza antitrombina y sus usos.
ES2114064T3 (es) Inmunoanalisis para la deteccion de colageno o fragmentos de colageno.
DK407987D0 (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
IT7927123A0 (it) Procedimento per la decarbonatazione di gas.
ES2115022T3 (es) Inmunoensayo de isotiazolonas.
ES2168253T3 (es) Peptidos especificos para hcmv y su utilizacion.
ES507991A0 (es) Perfeccionamientos introducidos en el metodo para la obtencion de gas sintetico de amoniaco.
ES2056919T3 (es) Anticuerpo monoclonal especifico para la fosfolipasa a2 pancreatica humana.
ES2099820T3 (es) Procedimiento para la preparacion de trans-piperidina-2,5-dicarboxilatos.
ES2044893T3 (es) Un anticuerpo monoclonal especifico para un inhibidor de la coagulacion.
ES2103017T3 (es) Sueros estandares y de control para empleo en ensayos para anticuerpos.
SE7910089L (sv) Vacciner
ES2090331T3 (es) Ctaa 28a32, antigeno reconocido por mca 28a32.
ES2055066T3 (es) Anticuerpos monoclonales que reconocen el extremo n del gamma polipeptido natriuretico atrial, hibridomas que los producen y su preparacion y aplicacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 306680

Country of ref document: ES